title: Abolished synthesis of cholic acid reduces atherosclerotic development in apolipoprotein E knockout mice.
abstract: To investigate the effects of abolished cholic acid (CA) synthesis in the ApoE knockout model [apolipoprotein E (apoE) KO],a double-knockout (DKO) mouse model was created by crossbreeding Cyp8b1 knockout mice (Cyp8b1 KO), unable to synthesize the primary bile acid CA, with apoE KO mice. After 5 months of cholesterol feeding, the development of atherosclerotic plaques in the proximal aorta was 50% less in the DKO mice compared with the apoE KO mice. This effect was associated with reduced intestinal cholesterol absorption, decreased levels of apoB-containing lipoproteins in the plasma, enhanced bile acid synthesis, reduced hepatic cholesteryl esters, and decreased hepatic activity of ACAT2. The upregulation of Cyp7a1 in DKO mice seemed primarily caused by reduced expression of the intestinal peptide FGF15. Treatment of DKO mice with the farnesoid X receptor (FXR) agonist GW4064 did not alter the intestinal cholesterol absorption, suggesting that the action of CA in this process is confined mainly to formation of intraluminal micelles and less to its ability to activate the nuclear receptor FXR. Inhibition of CA synthesis may offer a therapeutic strategy for the treatment of hyperlipidemic conditions that lead to atherosclerosis.
authors.affiliation: Unit for Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Katharina
authors.initials: K
authors.lastname: Slätis
authors.forename: Mats
authors.initials: M
authors.lastname: Gåfvels
authors.forename: Kristina
authors.initials: K
authors.lastname: Kannisto
authors.forename: Olga
authors.initials: O
authors.lastname: Ovchinnikova
authors.forename: Gabrielle
authors.initials: G
authors.lastname: Paulsson-Berne
authors.forename: Paolo
authors.initials: P
authors.lastname: Parini
authors.forename: Zhao-Yan
authors.initials: ZY
authors.lastname: Jiang
authors.forename: Gösta
authors.initials: G
authors.lastname: Eggertsen
mesh_terms: D000818:Animals; D001057:Apolipoproteins E / Q000097:blood / Q000172:deficiency* / Q000235:genetics*; D050197:Atherosclerosis / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D001646:Bile / Q000737:chemistry / Q000187:drug effects; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism; D002793:Cholic Acids / Q000096:biosynthesis* / Q000172:deficiency* / Q000378:metabolism; D055786:Gene Knockout Techniques; D007408:Intestinal Absorption / Q000187:drug effects; D007555:Isoxazoles / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008823:Micelles; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists / Q000378:metabolism; D000099150:Receptor, Farnesoid X-Activated
chemical_list: D001057:Apolipoproteins E; D002784:Cholesterol; D002793:Cholic Acids; D007555:Isoxazoles; D008823:Micelles; D018160:Receptors, Cytoplasmic and Nuclear; D000099150:Receptor, Farnesoid X-Activated; C412815:GW 4064